Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Precision Biosciences Inc (DTIL)
Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,411
  • Shares Outstanding, K 118,935
  • Annual Sales, $ 25,100 K
  • Annual Income, $ -111,640 K
  • 60-Month Beta 1.41
  • Price/Sales 1.68
  • Price/Cash Flow N/A
  • Price/Book 1.47
Trade DTIL with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.69
  • Most Recent Earnings -0.10 on 11/07/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 350.29% ( -505.68%)
  • Historical Volatility 110.44%
  • IV Percentile 44%
  • IV Rank 21.09%
  • IV High 1,161.99% on 06/30/23
  • IV Low 133.33% on 12/16/22
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 729
  • Open Int (30-Day) 711

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.10
  • Number of Estimates 1
  • High Estimate 0.10
  • Low Estimate 0.10
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +138.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3167 +15.25%
on 11/14/23
0.4695 -22.26%
on 11/20/23
-0.0340 (-8.52%)
since 11/01/23
3-Month
0.2750 +32.73%
on 10/27/23
0.4900 -25.51%
on 09/05/23
-0.1220 (-25.05%)
since 09/01/23
52-Week
0.2750 +32.73%
on 10/27/23
1.4500 -74.83%
on 01/13/23
-0.9650 (-72.56%)
since 12/01/22

Most Recent Stories

More News
Precision BioSciences: Q3 Earnings Snapshot

Precision BioSciences: Q3 Earnings Snapshot

DTIL : 0.3650 (+2.79%)
Precision BioSciences: Q2 Earnings Snapshot

Precision BioSciences: Q2 Earnings Snapshot

DTIL : 0.3650 (+2.79%)
Invest in These 3 Biotech Stocks Today

With the biotech industry experiencing significant growth due to the increasing demand for healthcare solutions, fundamentally sound stocks such as Amicus Therapeutics (FOLD), POINT Biopharma Global (PNT),...

DTIL : 0.3650 (+2.79%)
FOLD : 11.22 (+1.81%)
PNT : 13.80 (+1.47%)
Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates

Precision BioSciences (DTIL) delivered earnings and revenue surprises of -4.55% and 33.37%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

DTIL : 0.3650 (+2.79%)
PRQR : 1.7300 (+11.61%)
Precision BioSciences: Q1 Earnings Snapshot

Precision BioSciences: Q1 Earnings Snapshot

DTIL : 0.3650 (+2.79%)
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that, on April...

DTIL : 0.3650 (+2.79%)
Precision BioSciences to Report First Quarter 2023 Results on May 9, 2023

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that it will...

DTIL : 0.3650 (+2.79%)
Precision BioSciences to Present Preclinical In Vivo Gene Editing Research for its ARCUS HBV Program at Upcoming Global Hepatitis Summit 2023

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced an upcoming scientific...

DTIL : 0.3650 (+2.79%)
Precision BioSciences Announces Late-Breaking Abstract of Preclinical In Vivo Gene Editing Research Selected for Oral Presentation at the American Society of Gene & Cell Therapy 26th Annual Meeting

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that a late-breaking...

DTIL : 0.3650 (+2.79%)
Precision BioSciences Receives U.S. and International Patent Allowances for Proprietary PCSK9 ARCUS Nuclease

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced it has received...

DTIL : 0.3650 (+2.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products primarily in the United States. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. Precision BioSciences Inc. is based in Durham, North Carolina.

See More

Key Turning Points

3rd Resistance Point 0.3935
2nd Resistance Point 0.3818
1st Resistance Point 0.3734
Last Price 0.3650
1st Support Level 0.3533
2nd Support Level 0.3416
3rd Support Level 0.3332

See More

52-Week High 1.4500
Fibonacci 61.8% 1.0012
Fibonacci 50% 0.8625
Fibonacci 38.2% 0.7239
Last Price 0.3650
52-Week Low 0.2750

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar